GNH USA

Europe — EMA

Minirin Melt (Desmopressin)

GNH USA supplies Minirin Melt (Desmopressin), a vasopressin analog for central diabetes insipidus, nocturnal enuresis and bleeding disorders.

Desmopressin

Request sourcing

1
Pack/s

What is Desmopressin?

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a oral melt tablet for oral use. It treats central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as hemophilia A and von Willebrand disease.

GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Desmopressin used for?

Desmopressin is a synthetic vasopressin analog used to manage disorders of water balance and hemostasis.

Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. Bleeding disorders (e.g., hemophilia A, von Willebrand disease): promotes hemostasis by raising plasma factor VIII and von Willebrand factor levels.

What are the side effects of Desmopressin?

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hyponatremia: low blood sodium levels. - Headache. - Nausea. - Abdominal cramps. - Facial flushing. - Mild dizziness.

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma. - Water intoxication with cerebral edema. - Anaphylactic or severe allergic reactions. - Thromboembolic events. - Marked hypotension. - Cardiac arrhythmias.

What precautions apply to Desmopressin?

Before prescribing Minirin Melt, consider the following safety measures.

Monitor serum sodium: check electrolyte levels regularly, especially in patients at risk of hyponatremia. Adjust dose in renal impairment: reduce dosage in patients with reduced kidney function. Avoid excessive fluid intake: limit water consumption to prevent water overload. Use caution in elderly: increased susceptibility to hyponatremia. Pregnancy and lactation: safety not established; weigh benefits against potential risks. Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

What does Desmopressin interact with?

Desmopressin can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Carbamazepine: may reduce desmopressin efficacy. - Thiazide diuretics: increase risk of hyponatremia. - NSAIDs (e.g., ibuprofen): may potentiate antidiuretic effect. - Other antidiuretic agents (e.g., vasopressin analogs): risk of water retention. - SSRIs: heightened hyponatremia risk.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive effect. - Estrogen therapy: may increase antidiuretic response. - Opioids: possible additive sedation. - Other hemostatic agents: monitor for thrombotic risk. - CYP450 inducers: may alter drug metabolism modestly.

Frequently asked questions

What is Minirin Melt used for?+
Minirin Melt contains desmopressin and is prescribed for central diabetes insipidus, nocturnal enuresis in children and adults, and for hemostasis in bleeding disorders such as hemophilia A and von Willebrand disease. It works by reducing urine output and increasing clotting factor levels, helping to control excessive thirst, nighttime bedwetting, and bleeding episodes.
How does desmopressin work?+
Desmopressin is a synthetic analogue of the hormone vasopressin. It selectively activates V2 receptors in the kidney’s collecting ducts, which raises intracellular cAMP and promotes insertion of aquaporin‑2 channels, allowing more water to be reabsorbed. In the vascular endothelium, V2 activation increases release of factor VIII and von Willebrand factor, aiding blood clot formation.
What is the usual dose of Minirin Melt?+
The dose of Minirin Melt is individualized and set by the prescribing clinician based on the patient’s condition, age, renal function, and response to therapy. Dosage may be adjusted during treatment, and patients should follow the specific instructions provided by their healthcare professional.
Is Minirin Melt safe in pregnancy or breastfeeding?+
Safety of desmopressin during pregnancy and lactation has not been definitively established. The drug should be used only if the potential benefit justifies any possible risk to the fetus or infant. Physicians will evaluate the clinical situation and discuss potential risks with the patient before prescribing.
How do I order Minirin Melt from GNH USA?+
To order Minirin Melt, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing a formal quotation that includes pricing, availability, shipping details and any necessary import documentation.
How does Minirin Melt compare with other antidiuretic agents?+
Minirin Melt (desmopressin) offers a longer duration of action and a more convenient oral melt formulation compared with intranasal desmopressin sprays or injectable vasopressin. It provides a selective V2‑receptor effect, reducing the risk of vasoconstriction seen with non‑selective vasopressin analogues, while maintaining efficacy for water balance and hemostasis.
What are the storage and handling requirements for Minirin Melt?+
Minirin Melt should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original blister pack, protect them from moisture and direct sunlight, and avoid storing them in high‑humidity environments such as bathrooms.
How is Minirin Melt administered?+
Minirin Melt is taken orally. The tablet is placed on the tongue and allowed to melt completely without chewing or drinking water for a few minutes. After the tablet has dissolved, the patient may swallow any remaining saliva. Administration should follow the prescriber’s instructions regarding timing and any fluid restrictions.
What are the most serious risks associated with Minirin Melt?+
The most serious risks include severe hyponatremia, which can lead to seizures, cerebral edema, or coma, and water intoxication from excessive fluid retention. Rare but critical reactions such as anaphylaxis, thromboembolic events, marked hypotension, and cardiac arrhythmias may also occur. Patients should be monitored closely for signs of electrolyte imbalance.
Who should not use Minirin Melt?+
Minirin Melt is contraindicated in patients with known hypersensitivity to desmopressin or any excipients, in those with uncontrolled hyponatremia, severe renal impairment, or chronic water intoxication. Caution is also advised for individuals with a history of epilepsy, heart failure, or uncontrolled hypertension, as these conditions may increase the risk of adverse effects.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Desmopressin
Route
Oral Use
Manufacturer
Ferring N.V.
Origin
EU

Related products

Adin

Adin

Desmopressin

Ferring Léciva A.S.
EU
Anoctarin

Anoctarin

Desmopressin

Strides Nordic Aps
EU
Ddavp Melt

Ddavp Melt

Desmopressin

Ferring Pharmaceuticals Ltd.
EU
Ddavp Melt

Ddavp Melt

Desmopressin

Ferring Pharmaceuticals Ltd.
EU